Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan to reduce mortality in high-risk cardiac surgery patients
2009-013066-31Phase 4Completed
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levosimendan in low cardiac output syndrome (LCOS) (2 arms), sponsored by Fondazione Centro San Raffaele. Primary endpoint: 30-day all-cause mortality. Started Jun 2009; status: completed.
02
Drugs
levosimendan
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on 2009-013066-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013066-31.